You are currently viewing the summary.
View Full TextLog in to view the full text
AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.
More options
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
Summary
In shocking testimony last month in the U.S. District Court in San Francisco, a former researcher at Genentech Inc. of South San Francisco said that in 1978, he secretly removed a bacterial clone from a lab he had recently left at the University of California (UC), San Francisco and transferred it to his new employer. The witness, Peter Seeburg--who is now at the Max Planck Institute for Medical Research in Heidelberg--testified that the clone helped lead to Genentech's patent for the production of human growth hormone by bacterial synthesis. Seeburg testified for UC in a suit alleging that Genentech has been violating UC's own patent on growth hormone. The university is asking the court to award damages of about $400 million, according to a UC attorney.
